This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Features of advanced disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The criteria for advanced phase disease include:

  • increasing splenomegaly despite full doses of cytotoxic therapy
  • rapid white cell doubling
  • white count that responds poorly to cytotoxic therapy
  • anaemia or thrombocytopenia that responds poorly to cytotoxic therapy
  • thrombocytosis >1000x10^9/l
  • 10% blasts in the blood or marrow
  • 20% (blasts + promyelocytes) in the blood or marrow
  • acquisition of "non-random" chromosomal changes in addition to the Ph chromosome
  • myelofibrosis

Reference:

  • Goldman, J. (1997). ABC of clinical haematology. BMJ. 314, 657-660.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.